Hong Kong Stocks Today (Nov 10, 2025): Hang Seng Jumps 1.6% as China CPI Turns Positive; Pop Mart and CNOOC Lead Gains
10 November 2025
3 mins read

Hong Kong Stocks Today (Nov 10, 2025): Hang Seng Jumps 1.6% as China CPI Turns Positive; Pop Mart and CNOOC Lead Gains

Summary: Hong Kong equities rallied on Monday, November 10, 2025. The Hang Seng Index (HSI) climbed 1.55% to 26,649.06, powered by improving China inflation data and firmer global risk appetite. Energy, consumer and property-management names outperformed, while tech also advanced. 1


Market Snapshot — Monday, November 10, 2025

  • Hang Seng Index: 26,649.06 (+1.55%) at the close.
  • Hang Seng China Enterprises Index: 9,443.24 (+1.9%).
  • Hang Seng Tech Index: 5,915.56 (+1.34%). 1

Top intraday context: The rally followed a generally upbeat tone across global markets as investors priced in progress toward ending the U.S. government shutdown—lifting risk sentiment in Asia. 2


What Moved the Market

1) China inflation turned a corner—at least for now
Fresh data showed China’s CPI rose 0.2% year-on-year in October, while producer-price deflation narrowed to –2.1%. The improvement eased deflation concerns and supported Hong Kong risk assets. Economists cautioned the rebound could be uneven, but the print was enough to spark dip-buying. 3

2) Global risk-on tailwind
Stocks worldwide advanced on Monday as hopes increased that the U.S. Senate would move toward ending the government shutdown—bolstering appetite for cyclical and growth names in Asia, including Hong Kong. 2


Winners, Sectors and Standout Stocks

  • Pop Mart International (9992 HK) surged 8.1% to HK$221.40, topping the leaderboard as traders rotated into high-beta consumer names.
  • CNOOC (883 HK) jumped 6.0% to HK$22.44, helping lift energy shares.
  • China Resources Mixc Lifestyle (1209 HK) added 5.0% to HK$41.76, buoying property-management plays.
  • Technology gained broadly with the Hang Seng Tech Index up 1.3% into the close. 4

Market Breadth & Trading Color

The HSI advanced in a 26,303–26,669 intraday range after opening near 26,319, consolidating gains into the close as buyers stepped in across large-caps and Southbound-favored names. 5


Listings & Capital Markets Pulse

Softcare Limited (2698) made its Hong Kong debut today, underscoring a steady reopening of the IPO window into year-end. New-listing activity has been a supportive backdrop for turnover and risk sentiment. 6

Hong Kong’s primary and follow-on calendars have been active in recent weeks, with multiple sizeable tech and consumer deals and notable listings, keeping the city prominent in Asia’s fundraising league tables. 7


Macro Backdrop: What Investors Are Watching

  • China prices: October CPI’s return to growth and a smaller PPI decline hint at easing deflationary pressure, a constructive sign for margins and consumption-sensitive shares. Still, analysts warn the improvement could be bumpy without stronger demand. 3
  • Global risk sentiment: Progress toward ending the U.S. shutdown supported Asian equities and boosted cyclicals. Sustained momentum will likely depend on the durability of that policy outcome and incoming U.S./China data. 2

The Week Ahead: Key Catalysts for Hong Kong Stocks

  • Singles’ Day (11.11) in focus — Tuesday: Platforms have stretched the shopping window this year to up to five weeks to spur demand, so investors will parse platform updates and third-party trackers for any read-through to e‑commerce leaders and instant retail. 8
  • Earnings—China internet heavyweights:
    • Tencent (700 HK) reports Thursday, Nov 13 (HKT)—a major sentiment driver for Hong Kong tech. 9
    • Alibaba (9988 HK) is widely expected to report later this week; calendars currently point to Friday, Nov 14 (HKT), after the local close. (Timing unconfirmed by the company at this writing.) 10

Bottom Line

Hong Kong stocks kicked off the week on the front foot. A cleaner China inflation print and a firmer global tone powered a broad-based advance, with consumer, energy and property-management names leading and tech adding to gains. With Singles’ Day and Tencent/Alibaba earnings on deck, the next 72 hours will test whether today’s rebound can extend into a durable year-end rally. 3


Sources

  • Closing levels & sector leaders: South China Morning Post market wrap; updated 4:47pm HKT, Nov 10, 2025. 4
  • HSI/HSCEI/HSTECH closes: Xinhua market close report; Reuters quote page (HSTECH). 1
  • China CPI/PPI (October): Reuters data wrap, Nov 9, 2025. 3
  • Global risk backdrop: Reuters global markets update, Nov 10, 2025. 2
  • New listing: HKEX homepage—“HKEX Welcomes Softcare Limited (2698),” Nov 10, 2025. 6
  • Singles’ Day trading window: Reuters preview on retailers extending 11.11 campaigns, Oct 16, 2025. 8
  • Tencent earnings date: Tencent IR—Q3 2025 Results Announcement schedule, Nov 13, 2025. 9
  • Alibaba earnings timing (calendar): Yahoo Finance earnings calendar (unconfirmed), Nov 14, 2025. 10

Keywords: Hong Kong stock market today, Hang Seng Index today, HSI close 10 Nov 2025, Hong Kong stocks rally, China CPI October 2025, Hang Seng Tech Index, HSCEI, Pop Mart shares, CNOOC stock, Hong Kong IPO Softcare 2698, Singles’ Day 2025, Tencent earnings date, Alibaba earnings date.

Stock Market Today

NASA’s SPHEREx spots interstellar comet 3I/ATLAS flaring on its way out — and the chemistry surprised scientists

NASA’s SPHEREx spots interstellar comet 3I/ATLAS flaring on its way out — and the chemistry surprised scientists

7 February 2026
NASA’s SPHEREx telescope detected interstellar comet 3I/ATLAS sharply brightening in December 2025 as it left the solar system, with infrared data revealing a surge of gas and dust, including water vapor and organic molecules. The comet, only the third confirmed interstellar object, passed no closer than 1.8 astronomical units from Earth. China’s Tianwen-1 Mars orbiter also captured images of the comet.
AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
USD/CNY Today (10.11.2025): Yuan Holds Near 7.12 After Strong PBOC Fix — Outlook, Key Levels & What Could Move the Pair Next
Previous Story

USD/CNY Today (10.11.2025): Yuan Holds Near 7.12 After Strong PBOC Fix — Outlook, Key Levels & What Could Move the Pair Next

Tariffs Fail to Derail European Stock Rally as Markets Bounce Back
Next Story

GOOGL, NVDA, PFE, NIO, JOBY: 5 Fast‑Profit Catalysts to Watch Today (Nov. 10, 2025)

Go toTop